Tram Tran
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Tram Tran
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tram Tran tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | President | |
| MORPHOSYS AG | Biotechnology | Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| St. Louis College of Pharmacy | College/University | Doctorate Degree | |
| Columbia University Medical Center | College/University | Corporate Officer/Principal | |
| Instituto Tecnológico de Buenos Aires | College/University | Doctorate Degree | |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member | |
| Centro De Estudios En Ciencias De La Comunicacion | College/University | Graduate Degree | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | President | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of Metro Los Angeles is a non-profit organization that was founded in December 2015 to provide a sustainable solution to the opportunity crises facing vulnerable children in the neediest neighborhoods of Los Angeles. Boys & Girls Clubs of Metro Los Angeles is based in Los Angeles, CA, and has subsidiaries in the United States. The organization operates four clubs in Bell Gardens, Challengers, Downs, and Willowbrook, and offers nationally recognized, research-based programs and activities in three core areas: academic success, good character and citizenship, and healthy lifestyles. The organization empowers youth to explore a future with endless possibilities by offering creative programming, such as new approaches to science, technology, engineering, and math (STEM) created in collaboration with community partners. The non-profit company was founded in 2015, and the CEO is Patrick Mahoney. | Miscellaneous Commercial Services | Director/Board Member | |
| Roivant Social Ventures, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 19 |
| Regno Unito | 2 |
| Germania | 2 |
| Argentina | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 12 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 2 |
Posizioni
| Director/Board Member | 13 |
| Corporate Officer/Principal | 5 |
| President | 4 |
| Doctorate Degree | 4 |
| Chief Operating Officer | 4 |
Contatti più connessi
| Insiders | |
|---|---|
| Eric Venker | 12 |
| Andrew Cheng | 10 |
| Gaston Picchio | 4 |
- Borsa valori
- Insiders
- Tram Tran
- Connessioni Società
